°øÁö»çÇ×

HOME > ÇÐȸ¼Ò°³   >   °øÁö»çÇ×

Á¦ 1 Â÷ ASH Review Symposium ¾È³»
ÀÛ¼ºÀÚ
°ü¸®ÀÚ
ÀÛ¼ºÀÏ
2011-01-12
Á¶È¸
5964
Á¦ 1 Â÷ ASH Review Symposium

ÀϽÃ: 2011³â 1¿ù 22ÀÏ (Åä) 09:00 ~ 12:00

Àå¼Ò: »ï¼º¼­¿ïº´¿ø ¾Ï¼¾ÅÍ ÁöÇÏ1Ãþ ¼¼¹Ì³ª½Ç 1


ÃÊ´ëÀÇ ±Û

´ëÇÑÇ÷¾×ÇÐȸ Á¤¸ÆÇ÷Àü¿¬±¸È¸¿¡¼­´Â Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¤¸ÆÇ÷ÀüºÐ°ú¿Í °øµ¿À¸·Î Á¦ 1Â÷ Venous thromboembolism ASH Review¸¦ 1¿ù 22ÀÏ(Åä)¿¡ °³ÃÖ ÇÏ°íÀÚ ÇÕ´Ï´Ù.

2010³â 12¿ù ASH¿¡¼­ ¹ßÇ¥µÈ Education session ³»¿ë°ú Presentation ³»¿ëÀ» ´Ù½Ã Çѹø ¿©·¯ ¼±»ý´Ôµé°ú °øÀ¯ÇÔÀ¸·Î½á Á¤¸ÆÇ÷ÀüÁõ Áø·á¿Í ¿¬±¸¿¡ À¯¿ëÇÑ Áö½ÄÀÇ ÀåÀÌ µÇ¸®¶ó »ý°¢ÇÕ´Ï´Ù. ºÎµð ¸¹Àº ¼±»ý´Ôµé²²¼­ Âü¼®Çϼż­ Á¤¸ÆÇ÷ÀüÁõ¿¡ ´ëÇÑ ÃÖ½ÅÁö°ßÀ» ¾ò°í Åä·ÐÇÒ ¼ö ÀÖ´Â À¯ÀÍÇÑ ½Ã°£À» °¡Áö½Ã±æ ±â´ëÇÕ´Ï´Ù. °¨»çÇÕ´Ï´Ù.

´ëÇÑÇ÷¾×ÇÐȸ.Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¤¸ÆÇ÷Àü¿¬±¸È¸ À§¿øÀå ¿Àµµ¿¬

ÀÏÁ¤

09:00 ~ 09:10: Opening Remark
: ¿Àµµ¿¬ (Â÷ÀÇ°úÇдë Ç÷¾×Á¾¾ç³»°ú)

Session 1 ASH Education review: Issues in Thrombosis Management and Anticoagulation
Chair: ¿Àµµ¿¬ (Â÷ÀÇ°úÇдë Ç÷¾×Á¾¾ç³»°ú)

09:10 ~ 09:35 Warfarin Versus New Agents: Interpreting the Data
±è¿©°æ (Àü³²ÀÇ´ë Ç÷¾×Á¾¾ç³»°ú)

09:35 ~ 10:00 Post-Thrombotic Syndrome
ÀÓÈ£¿µ (ÀüºÏÀÇ´ë Ç÷¾×Á¾¾ç³»°ú)

10:00 ~ 10:25 Duration of Anticoagulation
¹ÚÀº°æ (Áß¾ÓÀÇ´ë Ç÷¾×Á¾¾ç³»°ú)

10:25 ~ 10:40 Break time

Session 2 ASH Presentation review
Chair: ±è¾ç±â (¼øõÇâÀÇ´ë È£Èí±â³»°ú)

10:40 ~ 11:00 Population Based Studies in Venous Thrombosis
Àå¹®ÁÖ (Â÷ÀÇ°úÇдë Ç÷¾×Á¾¾ç³»°ú)

11:00 ~ 11:20 Mechanisms of Venous Thrombosis
¼ÛÀç¿ì (¿¬¼¼ÀÇ´ë Áø´Ü°Ë»çÀÇÇаú)

11:20 ~ 11:40 Risk Factors for Venous Thrombosis
ÃÖ¿øÀÏ (°è¸íÀÇ´ë È£Èí±â³»°ú)

11:40 ~ 12:00 Antithrombotic Therapy
±è¼ºÇö (µ¿¾ÆÀÇ´ë Ç÷¾×Á¾¾ç³»°ú)

Closing Remark & Lunch


ÁÖ°ü: ´ëÇÑÇ÷¾×ÇÐȸ Á¤¸ÆÇ÷Àü¿¬±¸È¸.Çѱ¹Ç÷ÀüÁöÇ÷ÇÐȸ Á¤¸ÆÇ÷ÀüºÐ°ú °øµ¿

ÆòÁ¡: ´ëÇÑÀÇ»çÇùȸ ÆòÁ¡ 1Á¡